Lung cancer: perspectives and prospects.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002283:Carcinoma, Bronchogenic / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery; D018288:Carcinoma, Small Cell / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality; D003520:Cyclophosphamide / Q000627:therapeutic use; D004357:Drug Synergism; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery; D008466:Mechlorethamine / Q000627:therapeutic use; D011379:Prognosis
D000970:Antineoplastic Agents; D008466:Mechlorethamine; D003520:Cyclophosphamide; D006918:Hydroxyurea